[ad_1]
This week’s pullback in tech stocks was long overdue, but investors should wait for more earnings before “jumping in with both feet,” one analyst says.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...